# ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment

> **NCT00331097** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute, Naples** · enrollment: 300 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** docetaxel
- **DRUG:** cyclophosphamide
- **DRUG:** methotrexate
- **DRUG:** 5-fluorouracil

## Key facts

- **NCT ID:** NCT00331097
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-11
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331097, "ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00331097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*